Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3034 |
|
| Actual shortage: | 241 (8%) | |
| Anticipated shortage: | 18 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2766 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2020-10-14 | 2020-11-11 | 126254 |
| APO-LORAZEPAM | 2MG | TABLET | Resolved | 2021-08-03 | 2021-09-07 | 143401 |
| APO-LORAZEPAM | 2MG | TABLET | Resolved | 2021-12-01 | 2021-12-20 | 150252 |
| APO-HYDROMORPHONE | 2MG | TABLET | Resolved | 2022-02-04 | 2022-02-22 | 154175 |
| APO-LORAZEPAM | 2MG | TABLET | Resolved | 2022-04-01 | 2022-05-13 | 157698 |
| APO-GUANFACINE XR | 2MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-07-22 | 2022-08-06 | 165317 |
| APO-PERINDOPRIL | 2MG | TABLET | Resolved | 2022-07-29 | 2022-10-21 | 165730 |
| APO-PRUCALOPRIDE | 2MG | TABLET | Resolved | 2022-08-26 | 2022-12-16 | 168047 |
| APO-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2023-01-26 | 2023-03-30 | 182370 |
| APO-DOXAZOSIN | 2MG | TABLET | Resolved | 2023-02-23 | 2023-03-23 | 185451 |
| APO-PRAZO TAB 2MG | 2MG | TABLET | Actual shortage | 2023-04-06 | 2024-03-27 | 188943 |
| APO-PERINDOPRIL | 2MG | TABLET | Resolved | 2023-04-21 | 2023-05-06 | 190005 |
| APO-TERAZOSIN | 2MG | TABLET | Resolved | 2023-06-16 | 2024-04-02 | 195253 |
| APO-HYDROMORPHONE | 2MG | TABLET | Resolved | 2023-09-01 | 2023-09-28 | 203548 |
| APO-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2023-11-10 | 2023-12-01 | 209901 |
| APO-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2023-11-10 | 2023-12-01 | 209904 |
| APO-PRUCALOPRIDE | 2MG | TABLET | Resolved | 2023-11-10 | 2023-12-01 | 209922 |
| APO-PERINDOPRIL | 2MG | TABLET | Resolved | 2023-11-24 | 2023-12-08 | 211502 |
| APO-HYDROMORPHONE | 2MG | TABLET | Resolved | 2023-12-01 | 2024-01-12 | 212383 |
| APO-GUANFACINE XR | 2MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-12-08 | 2024-01-12 | 212949 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LISINOPRIL/HCTZ | 12.5MG 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1093 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71054 |
| APO-LISINOPRIL/HCTZ | 12.5MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1090 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
| APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60603 |
| APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71101 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40823 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40826 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 40957 |
| APO-CARVEDILOL | 12.5MG | TABLET | To be discontinued | 2024-01-26 | 2024-04-01 | 217493 |
| APO-DILTIAZ TZ | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1064 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | 125MG 31.25MG | POWDER FOR SUSPENSION | Discontinued | 2017-03-31 | 2017-03-31 | 4903 |
| APO-AMOXI SUGAR FREE | 125MG | POWDER FOR SUSPENSION | Discontinued | 2018-09-07 | 2018-09-15 | 60246 |